Work

Preclinical and early clinical data of ZN-1041 in combination with trastuzumab deruxtecan to treat breast cancer with or without CNS metastases.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.1041

Authors: Carey K. Anders, Nancy U. Lin, Aarti Chand, Tingting Fu, Di Zhu, Zheng Wang, Ding Zhou, Ziqiang (Zack) Cheng

Institutions: Duke University, Duke Cancer Institute, Dana-Farber Cancer Institute, Oncology Institute of Hope and Innovation

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379328087

Cites:

Cited by: 5

Related to: 10